The androgen-receptor isoform encoded by splice variant 7 (AR-V7) lacks the ligand-binding domain, leading to constitutive activation of the androgen receptor, and its detection in circulating tumor cells (CTC) has been associated with resistance to ARSi [3]. Here, AR is linked to neoplasm.